Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Usana Health Sciences (USNA) Non Operating Income (2016 - 2026)

Usana Health Sciences (USNA) has disclosed Non Operating Income for 17 consecutive years, with $358000.0 as the latest value for Q1 2026.

  • Quarterly Non Operating Income rose 104.06% to $358000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $3.4 million through Jan 2026, up 191.94% year-over-year, with the annual reading at $4.1 million for FY2026, 505.04% up from the prior year.
  • Non Operating Income for Q1 2026 was $358000.0 at Usana Health Sciences, down from $570000.0 in the prior quarter.
  • The five-year high for Non Operating Income was $9.0 million in Q4 2023, with the low at -$8.8 million in Q4 2024.
  • Average Non Operating Income over 5 years is $795058.8, with a median of $756000.0 recorded in 2025.
  • The sharpest move saw Non Operating Income crashed 769.86% in 2022, then surged 652.73% in 2023.
  • Over 5 years, Non Operating Income stood at -$3.3 million in 2022, then surged by 369.19% to $9.0 million in 2023, then crashed by 197.91% to -$8.8 million in 2024, then skyrocketed by 106.46% to $570000.0 in 2025, then plummeted by 37.19% to $358000.0 in 2026.
  • According to Business Quant data, Non Operating Income over the past three periods came in at $358000.0, $570000.0, and $1.7 million for Q1 2026, Q3 2025, and Q2 2025 respectively.